Cover Image

Comment: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Saved in:

Bibliographic Details
Main Authors:	Chin-Yuan Yii (Author), Hsien Hung Chiu (Author), Su-Boon Yong (Author)
Format:	Book
Published:	Elsevier, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023)

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023)

Comment on "Effect of probiotic strain, Lactiplantibacillus plantarum P9, on chronic constipation: A randomized, double-blind, placebo-controlled study"
by: Ting Wei Su, et al.
Published: (2023)

Comment on "Efficacy and safety of Gutong Patch compared with NSAIDs for knee osteoarthritis: A real-world multicenter, prospective cohort study in China"
by: Chi-Tung Lu, et al.
Published: (2024)

Correspondence: Study Comparing Gutong Patch and NSAIDs in Treating Knee Osteoarthritis
by: Hung-Hsuan Wang, et al.
Published: (2024)

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
by: Zhen Zeng, et al.
Published: (2024)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
by: Romain Altwegg, et al.
Published: (2014)

Correspondence "Validation of fermentation techniques for prebiotic impact on gut microbiota"
by: Daniel Yu-Hsien Chang, et al.
Published: (2024)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017)

Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
by: Joanna Balding, et al.
Published: (2004)

Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
by: Bruno Laganà, et al.
Published: (2019)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021)

peu-MIR2916-p3-enriched garlic exosomes ameliorate murine colitis by reshaping gut microbiota, especially by boosting the anti-colitic Bacteroides thetaiotaomicron - Correspondence
by: Xin-Zhi Huang, et al.
Published: (2024)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
by: Cui Zhang, et al.
Published: (2018)

Genetic polymorphisms in TNF-α as a potential biomarker for oral health-related quality of life in children
by: Lívia Azeredo Alves Antunes, et al.
Published: (2022)

Chronological Review of Endoscopic Indices in Inflammatory Bowel Disease
by: Joon Seop Lee, et al.
Published: (2019)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021)

Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors
by: Anne-Sophie Darrigade, et al.
Published: (2017)

Investigating IL-22 gene polymorphism in patients afflicted with inflammatory bowel disease
by: Ali Moravej, et al.
Published: (2017)

Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
by: Silvia Marquez-Megias, et al.
Published: (2022)

Inflammatory biomarkers as prognostic indicators for liver cirrhosis
by: Naglaa Abou-Elfattah Tawfik, et al.
Published: (2019)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
by: Dahham Alsoud, et al.
Published: (2022)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
by: Cao Y, et al.
Published: (2021)

Association of Tumor Necrosis Factor Alpha Gene Polymorphisms with Inflammatory Bowel Disease in Iran.
by: Nosratollah Naderi, et al.
Published: (2014)

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
by: Al-Meghaiseeb ES, et al.
Published: (2016)

A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model
by: Songmao Zheng, et al.
Published: (2020)

Comments to Metallothionein as an Anti-Inflammatory Mediator
by: Yong-Song Guan
Published: (2009)

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
by: Tetsuhiro Yoshimura, et al.
Published: (2021)

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients
by: Meng Sun, et al.
Published: (2024)

Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents
by: Vu Q. Nguyen, et al.
Published: (2021)

Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease
by: Weigang Shu, et al.
Published: (2019)

Nutritional concerns in pediatric inflammatory bowel disease
by: Yong Joo Kim
Published: (2016)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010)

The TNF-α-308G/A Gene Polymorphism and Serum TNF-α Levels in Women With Preeclampsia
by: Allahdad Khodadadi, et al.
Published: (2022)

Plasma Inflammatory Biomarkers Indicative of Aging and Overweight in Brazilian Women
by: Débora Nonato Miranda de Toledo, et al.
Published: (2024)

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?
by: Michal Walczak, et al.
Published: (2020)

Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
by: Rishab Revankar, et al.
Published: (2023)

Tumor necrosis factor alpha (TNFα)-binding imprinted polymers. A non-systemic therapeutic approach for inflammatory bowel diseases
by: Rina Arad Yellin, et al.
Published: (2023)

Comment on "Estrogen deficiency induces bone loss through the gut microbiota"
by: Priscilla Detweiler, et al.
Published: (2024)

Recurrent pregnancy loss: TNF-α and IL-10 polymorphisms
by: Amrit Kaur, et al.
Published: (2011)